JP2021534184A5 - - Google Patents
Info
- Publication number
- JP2021534184A5 JP2021534184A5 JP2021507917A JP2021507917A JP2021534184A5 JP 2021534184 A5 JP2021534184 A5 JP 2021534184A5 JP 2021507917 A JP2021507917 A JP 2021507917A JP 2021507917 A JP2021507917 A JP 2021507917A JP 2021534184 A5 JP2021534184 A5 JP 2021534184A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- exist
- composition according
- pharmaceutical composition
- exists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024074284A JP7822065B2 (ja) | 2018-08-17 | 2024-05-01 | 急性肺損傷の処置のための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862719217P | 2018-08-17 | 2018-08-17 | |
| US62/719,217 | 2018-08-17 | ||
| PCT/US2019/046698 WO2020037146A1 (en) | 2018-08-17 | 2019-08-15 | Compositions and methods for treatment of acute lung injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074284A Division JP7822065B2 (ja) | 2018-08-17 | 2024-05-01 | 急性肺損傷の処置のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534184A JP2021534184A (ja) | 2021-12-09 |
| JP2021534184A5 true JP2021534184A5 (enExample) | 2022-08-19 |
| JP7483684B2 JP7483684B2 (ja) | 2024-05-15 |
Family
ID=69524874
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507917A Active JP7483684B2 (ja) | 2018-08-17 | 2019-08-15 | 急性肺損傷の処置のための組成物および方法 |
| JP2024074284A Active JP7822065B2 (ja) | 2018-08-17 | 2024-05-01 | 急性肺損傷の処置のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024074284A Active JP7822065B2 (ja) | 2018-08-17 | 2024-05-01 | 急性肺損傷の処置のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12070483B2 (enExample) |
| EP (1) | EP3836953A4 (enExample) |
| JP (2) | JP7483684B2 (enExample) |
| KR (1) | KR20210046698A (enExample) |
| CN (1) | CN112703009B (enExample) |
| AU (1) | AU2019321654B8 (enExample) |
| BR (1) | BR112021002920A2 (enExample) |
| CA (1) | CA3109798A1 (enExample) |
| IL (1) | IL280868B1 (enExample) |
| MX (1) | MX2021001877A (enExample) |
| WO (1) | WO2020037146A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL280868B1 (en) | 2018-08-17 | 2026-05-01 | The Trustees Of The Univ Of Pennsylvania | Compositions and methods for treating acute lung injury |
| KR20260034620A (ko) * | 2023-05-05 | 2026-03-11 | 페록시테크 인코포레이티드. | 패혈성 쇼크 치료용 조성물 및 방법 |
| US20240390452A1 (en) * | 2023-05-26 | 2024-11-28 | The Trustees Of The University Of Pennsylvania | Protective Agent Against Endothelial Dysfunction |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861756A (en) * | 1988-03-08 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Synthetic pulmonary surfactant |
| US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
| US5582837A (en) | 1992-03-25 | 1996-12-10 | Depomed, Inc. | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| ATE173159T1 (de) | 1992-03-25 | 1998-11-15 | Depomed Systems Inc | Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe |
| WO1997047285A1 (en) | 1996-06-10 | 1997-12-18 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| US6635280B2 (en) | 1997-06-06 | 2003-10-21 | Depomed, Inc. | Extending the duration of drug release within the stomach during the fed mode |
| ES2248908T7 (es) | 1997-06-06 | 2014-11-24 | Depomed, Inc. | Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles |
| NZ518739A (en) | 1999-11-02 | 2004-12-24 | Depomed Inc | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| PT1251832E (pt) | 2000-02-04 | 2007-01-31 | Depomed Inc | Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero |
| US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| WO2002006301A2 (en) * | 2000-06-30 | 2002-01-24 | University Of Cincinnati | Peptides with antioxidant and antimicrobial properties |
| US6451808B1 (en) | 2000-10-17 | 2002-09-17 | Depomed, Inc. | Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
| US20030031711A1 (en) | 2001-05-29 | 2003-02-13 | Fara John W. | Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough |
| US20030091630A1 (en) | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| JP2005508358A (ja) | 2001-10-25 | 2005-03-31 | デポメド・インコーポレイテッド | 胃滞留型ロサルタン投与量を用いる治療方法 |
| CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| MXPA04010560A (es) * | 2002-04-25 | 2005-08-15 | Scripps Research Inst | Tratamiento y prevencion de condiciones pulmonares. |
| EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
| US9012403B2 (en) * | 2010-06-18 | 2015-04-21 | Xiberscience Gmbh | Peptides as active agents to stabilize biological barriers |
| US8962570B2 (en) * | 2011-05-17 | 2015-02-24 | University of Pittsburgh—of the Commonwealth System of Higher Education | Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism |
| US11110152B2 (en) * | 2016-04-11 | 2021-09-07 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating and preventing lung disease |
| IL280868B1 (en) | 2018-08-17 | 2026-05-01 | The Trustees Of The Univ Of Pennsylvania | Compositions and methods for treating acute lung injury |
-
2019
- 2019-08-15 IL IL280868A patent/IL280868B1/en unknown
- 2019-08-15 MX MX2021001877A patent/MX2021001877A/es unknown
- 2019-08-15 US US17/269,097 patent/US12070483B2/en active Active
- 2019-08-15 JP JP2021507917A patent/JP7483684B2/ja active Active
- 2019-08-15 KR KR1020217007331A patent/KR20210046698A/ko not_active Ceased
- 2019-08-15 WO PCT/US2019/046698 patent/WO2020037146A1/en not_active Ceased
- 2019-08-15 CN CN201980060751.3A patent/CN112703009B/zh active Active
- 2019-08-15 CA CA3109798A patent/CA3109798A1/en active Pending
- 2019-08-15 AU AU2019321654A patent/AU2019321654B8/en active Active
- 2019-08-15 EP EP19850140.5A patent/EP3836953A4/en active Pending
- 2019-08-15 BR BR112021002920-6A patent/BR112021002920A2/pt unknown
-
2024
- 2024-05-01 JP JP2024074284A patent/JP7822065B2/ja active Active
- 2024-07-16 US US18/773,968 patent/US20250082715A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2129562C1 (ru) | Производные циклических пептидов или их фармацевтически приемлемые соли, способ получения, фармацевтическая композиция | |
| JP2019194251A5 (enExample) | ||
| JP2019196370A5 (enExample) | ||
| JP2013543501A5 (enExample) | ||
| EP1098906B1 (en) | Peptide analogues of pacap | |
| JP2006514024A5 (enExample) | ||
| WO1996012736A3 (en) | COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY | |
| RU98123833A (ru) | Способы и композиции, используемые для ингибирования ангиогенеза | |
| JP2010500399A5 (enExample) | ||
| JP2003509020A5 (enExample) | ||
| JP2011500814A5 (enExample) | ||
| JP2008521840A5 (enExample) | ||
| JP2023500248A5 (enExample) | ||
| JP2006508039A5 (enExample) | ||
| JP2002521468A5 (enExample) | ||
| RU2012157399A (ru) | Пептиды в качестве активных агентов для стабилизации биологических барьеров | |
| KR970701724A (ko) | 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin) | |
| FI3773664T3 (fi) | Syklosporiiniformulaatioita käytettäväksi tukkeavan bronkioliittioireyhtymän (bos) hoitamisessa | |
| JP2023524911A5 (enExample) | ||
| JP2024537297A5 (enExample) | ||
| JP2023536132A (ja) | 特発性肺線維症の予防または治療用ポリペプチド及びそれらを含む医薬組成物 | |
| JP2004506017A (ja) | 抗真菌剤組合せ使用 | |
| JP4800194B2 (ja) | 乾癬の治療薬を製造するためのカハラリド化合物の使用 | |
| JP2015514771A5 (enExample) | ||
| JP2007516214A5 (enExample) |